The open index of psychedelic research

The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function

Neural Effects of Intravenous N,N-dimethyltryptamine (DMT)

A rapid systematic review of palliative uses of ketamine for depression and pain in people living with advanced cancer.

Tometich DB, Hersh CL, Murphy MA +4

[Simultaneous determination of three tryptamines in foods by ultra performance liquid chromatography-tandem mass spectrometry coupled with hydrophilic column separation].

Liao XL, Lin Q, Mei Y +5

530. Detecting neuroplastic effects induced by ketamine and classic psychedelics in healthy human subjects

Behavioural Activation Therapy and Ketamine for Treatment-Resistant Depression

Ketamine enhances ketogenic diet-induced resilience to activity-based anorexia of adult mice through hippocampal synaptic plasticity.

Wang J, Ge O, Dong Y +2

720. Unraveling anxiolytic and anti-addictive properties of lysergic acid diethylamide in a model of alcohol use disorder

784. A Retrospective Report of Efficacy and Tolerability of Low Daily Dose Ketamine for Depression and Anxiety in a Large Population Sample

188. A single high-dose acute injection of 5-MeO-DMT reverses stress-induced anhedonia in rats

Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure

805. Rapid Antidepressant-Like Effects of 5-MeO-DMT Require Both 5-HT1A and 5-HT2A Receptors

515. Influence of the context of administration on 5-MeO-DMT-promoted antidepressant-like effects and neuroplasticity

716. A randomised-controlled feasibility study of ketamine for the treatment of depression with anorexia nervosa

Optimizing Ketamine Infusion Therapy for Treatment-Resistant Bipolar Depression: Commentary on Zhou et al. (2023).

Lin CC, Wei LC

Factors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.

Meier BP, Lappas CM, Johnson MW

Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUD

Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double-Blind Trial.

Lafuma P, Magaud L, Abichou-Klich A +10

Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder

Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)

Psilocybin as a Novel Therapy for Residual Anhedonia

475. Psilocin pharmacokinetics and exposure-response relationships in Japanese patients with treatment-resistant depression receiving psilocybin therapy: an open-label study

433. Psilocybin reveals diverse antidepressant efficacies across different preclinical models of depression

230. LSD microdosing for depression: hype or hope? A randomised controlled trial in major depressive disorder